Diagnostic Hybrids develops, manufactures, and markets diagnostic cell cultures and virus detection kit systems used in the clinical diagnosis of infectious and autoimmune diseases.  The company was acquired by Quidelortho Corporation (NASDAQ: QDEL) in January 2010.